HEY2 and hepatocellular carcinoma: In a study conducted by Dan-Chun Wu [83], HEY2 expression was significantly associated with poor overall and disease-free survival in patients with hepatocellular carcinoma (HCC), and its knockdown resulted in the opposite phenotype.